Imperial College London

ProfessorMarkThursz

Faculty of MedicineDepartment of Metabolism, Digestion and Reproduction

Professor of Hepatology. Head of Department
 
 
 
//

Contact

 

+44 (0)20 3312 1903m.thursz

 
 
//

Assistant

 

Ms Dawn Campbell +44 (0)20 3312 6454

 
//

Location

 

Norfolk PlaceSt Mary's Campus

//

Summary

 

Summary

Mark Thursz is professor of hepatology at Imperial College and consultant in hepatology at St Mary's Hospital, London. His clinical interests are in viral hepatitis, alcoholic liver disease and fatty liver disease. He is currently interested in developing programmes for treatment of chronic hepatitis B infection in resource poor settings to reduce the risk of hepatocellular carcinoma.

Professor Thursz' research interests are focussed on the natural history of viral hepatitis and fatty liver disease and the factors which determine chronic infection and progressive liver disease. He has a special interest in the genetic determinants of disease outcomes using genetic association and genome wide scanning to identify causative variants.

Professor Thursz is chief investigator on two multi-centre trials: The warfarin anticoagulation for liver fibrosis in patients transplanted for hepatitis C (WAFT-C) trial and the steroids or pentoxifylline for alcoholic hepatitis (STOPAH) trial.

Professor Thursz is a former secretary of the British Association for Study of the Liver (BASL) and is currently vice-secretary of the European Association for Study of the Liver. In this role he has special responsibility for EU policy and advocacy in Brussels.

 

Publications

Journals

U MRA, Shen EY-L, Cartlidge C, et al., 2022, Optimised systematic review tool: Application to candidate biomarkers for the diagnosis of hepatocellular carcinoma, Cancer Epidemiology, Biomarkers and Prevention, Vol:31, ISSN:1055-9965, Pages:1261-1274

Szabo G, Thursz M, Shah VH, 2022, Therapeutic advances in alcohol-associated hepatitis, Journal of Hepatology, Vol:76, ISSN:0168-8278, Pages:1279-1290

Morales-Arraez D, Ventura-Cots M, Altamirano J, et al., 2022, The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study (vol 117, pg 301, 2022), American Journal of Gastroenterology, Vol:117, ISSN:0002-9270, Pages:818-818

Atkinson SR, Aly M, Remih K, et al., 2022, Serum keratin 19 (CYFRA21-1) is a prognostic biomarker in severe alcoholic hepatitis, Liver International, Vol:42, ISSN:1478-3223, Pages:1049-1057

Morales-Arraez D, Ventura-Cots M, Altamirano J, et al., 2022, The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study, American Journal of Gastroenterology, Vol:117, ISSN:0002-9270, Pages:301-310

More Publications